Euveda Biosciences

Developing platform microfluidic technologies that enable drug screening on primary cells

placeBaltimore, Maryland, United States calendar_todayFounded 2011 language euvedabiosciences.com

Innovation

1 patent family (1 granted) — focus: Operations & transport; filing pace dormant. Cited 18 times.

YearFilings
20151
20171

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon